December 5, 2025 · Form 4 insider transaction
EASTHAM KARIN bought 10,000 shares of Veracyte, Inc. at $7.94 per share, a transaction worth $79.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025.